Provider profile · Membership plus medication

Hims review: services, costs, and questions

Hims' current weight-loss membership and medication pathway, with attention to approved versus compounded product identity.

Sources checked · Official page retrieved · Medical review pending

A teal laptop, a burgundy folder, a blank receipt, and an envelope on a desk.
Care and costs, illustrated. This is not a photograph of a listed provider or service.
Evidence boundary: This is a review of public information, not a hands-on treatment assessment. We have not independently audited pharmacies, clinician credentials, response times, or patient outcomes. We do not assign a star rating.

What the official information says

The official Hims weight-loss page advertises a care membership and treatment options. Current search and page research identify approved-product pathways as well as a changing history of compounded weight-loss offers.

The medication name and formulation on the actual prescription matter more than a generic GLP-1 heading. Ask whether you are being offered a branded product, a separately approved generic, or a compounded preparation; each has its own evidence and terms.

Sources: Hims weight-loss program

Pricing and the full bill

The current advertised membership is $39 for the first month and $149 per month afterward, billed separately from medication. Confirm the pharmacy price, dose, visit coverage, and any required ongoing membership. Different product pathways should not be combined into one low starting price.

A first-month price is not a reliable annual budget. Ask for the amount charged today, the renewal interval, the cost after any promotion, and whether medication, supplies, visits, labs, and shipping are included. Obtain cancellation and refund terms before paying, particularly if a prescription has not yet been approved.

Sources: Hims weight-loss program

Limitations that affect your decision

Earlier descriptions of the company's compounded offerings may be outdated. A current official quote should be the source of the treatment and billing details.

FDA's concerns about unapproved GLP-1 drugs apply to compounded formulations. Do not equate a compounded oral product with approved Wegovy tablets or infer an efficacy advantage from personalization language.

Medication trials evaluate specific formulations, doses, and study populations. A provider advertising semaglutide or tirzepatide has not thereby demonstrated that its own treatment produces the results of Wegovy or Zepbound trials. A compounded medicine is not FDA-approved and should not be described as an approved generic equivalent.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss · FDA clarification of compounding policies as GLP-1 supply stabilizes

Questions to ask before enrollment

  • Which approved or compounded product is the current offer for, and what is the dispensing pharmacy?
  • Can I continue the prescription if I stop the membership?
  • What exact medicine, formulation, and device would I receive, and which pharmacy dispenses it?
  • Who prescribes in my state, and how do I obtain urgent clinical help?
  • What will I pay at maintenance, and when do renewals and cancellation deadlines occur?

Ask the prescribing clinician how your other medicines, diabetes treatment, pregnancy plans, gastrointestinal history, and follow-up needs affect eligibility. Check the dispensing pharmacy with the relevant state board. A reassuring website or testimonial does not replace those checks.

Sources: FDA concerns with unapproved GLP-1 drugs used for weight loss